Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the 'Arbeitsgemeinschaft Internistische Onkologie' - Haas, M; Siveke, J T; Schenk, M (European journal of cancer (Oxford, England: 1990), 2018)
et al.